메뉴 건너뛰기




Volumn 111, Issue 2, 2005, Pages 106-115

Randomized double blind comparison of olanzapine vs. clozapine on subjective well-being and clinical outcome in patients with schizophrenia

Author keywords

Antipsychotic agents; Quality of life; Randomized controlled trials; Schizophrenia

Indexed keywords

CLOZAPINE; OLANZAPINE;

EID: 20044376675     PISSN: 0001690X     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1600-0447.2004.00486.x     Document Type: Article
Times cited : (94)

References (44)
  • 1
    • 0029558065 scopus 로고
    • A self-rating to measure subjective effects of neuroleptic drug relationships to objective psychopathology, quality of life, compliance, and other clinical variables
    • NABER D. A self-rating to measure subjective effects of neuroleptic drug relationships to objective psychopathology, quality of life, compliance, and other clinical variables. Int Clin Psychopharmacol 1995;10(Suppl. 3):133-138.
    • (1995) Int Clin Psychopharmacol , vol.10 , Issue.SUPPL. 3 , pp. 133-138
    • Naber, D.1
  • 2
    • 0029946130 scopus 로고    scopus 로고
    • Assessment of the patient's subjective experience in acute neuroleptic treatment: Implications for compliance and outcome
    • AWAD AG, VORUGANTI LN, HESLEGRAVE RJ, HOGAN TP. Assessment of the patient's subjective experience in acute neuroleptic treatment: implications for compliance and outcome. Int Clin Psychopharmacol 1996;11(Suppl. 2):55-59.
    • (1996) Int Clin Psychopharmacol , vol.11 , Issue.SUPPL. 2 , pp. 55-59
    • Awad, A.G.1    Voruganti, L.N.2    Heslegrave, R.J.3    Hogan, T.P.4
  • 3
    • 0036307453 scopus 로고    scopus 로고
    • Relapse and rehospitalisation rates in patients with schizophrenia: Effects of second generation antipsychotics
    • CSERNANSKY JG, SCHUCHART EK. Relapse and rehospitalisation rates in patients with schizophrenia: effects of second generation antipsychotics. CNS Drugs 2002;16:473-484.
    • (2002) CNS Drugs , vol.16 , pp. 473-484
    • Csernansky, J.G.1    Schuchart, E.K.2
  • 4
    • 0036305380 scopus 로고    scopus 로고
    • Patients' subjective experiences of antipsychotics. Clinical relevance
    • HELLEWELL J. Patients' subjective experiences of antipsychotics. Clinical relevance. CNS Drugs 2002;16:457-471.
    • (2002) CNS Drugs , vol.16 , pp. 457-471
    • Hellewell, J.1
  • 5
    • 0032601816 scopus 로고    scopus 로고
    • Subjective experience and mental side-effects of antipsychotic treatment
    • GERLACH J, LARSEN EB. Subjective experience and mental side-effects of antipsychotic treatment. Acta Psychiatr Scand 1999;99(Suppl. 395):113-117.
    • (1999) Acta Psychiatr Scand , vol.99 , Issue.SUPPL. 395 , pp. 113-117
    • Gerlach, J.1    Larsen, E.B.2
  • 7
    • 0035032145 scopus 로고    scopus 로고
    • Influence of novel and conventional antipsychotic medication on subjective quality of life
    • TEMPIER R, PAWLIUK N. Influence of novel and conventional antipsychotic medication on subjective quality of life. J Psychiatr Neurosci 2001;26:131-136.
    • (2001) J Psychiatr Neurosci , vol.26 , pp. 131-136
    • Tempier, R.1    Pawliuk, N.2
  • 8
    • 0035987326 scopus 로고    scopus 로고
    • Subjective well-being and quality of life under atypical antipsychotic treatment
    • KAROW A, NABER D. Subjective well-being and quality of life under atypical antipsychotic treatment. Psychopharmacology 2002;162:3-10.
    • (2002) Psychopharmacology , vol.162 , pp. 3-10
    • Karow, A.1    Naber, D.2
  • 9
    • 0034674458 scopus 로고    scopus 로고
    • Comparative evaluation of conventional and novel antipsychotic drugs with reference to their subjective tolerability, side-effect profile and impact on quality of life
    • VORUGANTI L, CORTESE L, OYEWUMI L, CERNOVSKY T, ZIRUL S, AWAD A. Comparative evaluation of conventional and novel antipsychotic drugs with reference to their subjective tolerability, side-effect profile and impact on quality of life. Schizophr Res 2000;43:135-145.
    • (2000) Schizophr Res , vol.43 , pp. 135-145
    • Voruganti, L.1    Cortese, L.2    Oyewumi, L.3    Cernovsky, T.4    Zirul, S.5    Awad, A.6
  • 10
    • 0036641765 scopus 로고    scopus 로고
    • Personal evaluation of transitions in treatment (PETiT):a scale to measure subjective aspects of antipsychotic drug therapy in schizophrenia
    • VORUGANTI LN, AWAD AG. Personal evaluation of transitions in treatment (PETiT):a scale to measure subjective aspects of antipsychotic drug therapy in schizophrenia. Schizophr Res 2002;56:37-46.
    • (2002) Schizophr Res , vol.56 , pp. 37-46
    • Voruganti, L.N.1    Awad, A.G.2
  • 11
    • 2442688064 scopus 로고    scopus 로고
    • Subjective response to antipsychotics of schizophrenia patients treated in routine clinical practice. A naturalistic comparative study
    • RITSNER M, PERELROYZEN G, ILAN H, GIBEL A. Subjective response to antipsychotics of schizophrenia patients treated in routine clinical practice. A naturalistic comparative study. J Clin Psychopharmacol 2004;3:245-253.
    • (2004) J Clin Psychopharmacol , vol.3 , pp. 245-253
    • Ritsner, M.1    Perelroyzen, G.2    Ilan, H.3    Gibel, A.4
  • 14
    • 0023812652 scopus 로고
    • Clozapine for the treatment-resistant schizophrenic. A double-blind comparison with chlorpromazine
    • KANE JM, HONIGFELD G, SINGER J, MELTZER H. Clozapine for the treatment-resistant schizophrenic. A double-blind comparison with chlorpromazine. Arch Gen Psychiatry 1988;45:789-796.
    • (1988) Arch Gen Psychiatry , vol.45 , pp. 789-796
    • Kane, J.M.1    Honigfeld, G.2    Singer, J.3    Meltzer, H.4
  • 15
    • 0033558072 scopus 로고    scopus 로고
    • Comparative efficacy of olanzapine and haloperidol for patients with treatment-resistant schizophrenia
    • BREIER A, HAMILTON SH. Comparative efficacy of olanzapine and haloperidol for patients with treatment-resistant schizophrenia. Biol Psychiatry 1999;45:403-411.
    • (1999) Biol Psychiatry , vol.45 , pp. 403-411
    • Breier, A.1    Hamilton, S.H.2
  • 17
    • 0033008580 scopus 로고    scopus 로고
    • Evidence of clozapine's effectiveness in schizophrenia: A systematic review and meta-analysis of randomized trials
    • WAHLBECK K, CHEINE M, ESSALI A, ADAMS C. Evidence of clozapine's effectiveness in schizophrenia: a systematic review and meta-analysis of randomized trials. Am J Psychiatry 1999;156:990-999.
    • (1999) Am J Psychiatry , vol.156 , pp. 990-999
    • Wahlbeck, K.1    Cheine, M.2    Essali, A.3    Adams, C.4
  • 18
    • 0035060791 scopus 로고    scopus 로고
    • Double-blind comparison of olanzapine versus clozapine in schizophrenic patients clinically eligible for treatment with clozapine
    • TOLLEFSON GD, BIRKETT MA, KIESLER GM, WOOD AJ and the Lilly Resistant Schizophrenia Study Group. Double-blind comparison of olanzapine versus clozapine in schizophrenic patients clinically eligible for treatment with clozapine. Biol Psychiatry 2001;49:52-63.
    • (2001) Biol Psychiatry , vol.49 , pp. 52-63
    • Tollefson, G.D.1    Birkett, M.A.2    Kiesler, G.M.3    Wood, A.J.4
  • 19
    • 0036159250 scopus 로고    scopus 로고
    • Clozapine, olanzapine, risperidone, and haloperidol in the treatment of patients with chronic schizophrenia and schizoaffective disorder
    • VOLAVKA J, CZOBOR P, SHEITMAN B et al. Clozapine, olanzapine, risperidone, and haloperidol in the treatment of patients with chronic schizophrenia and schizoaffective disorder. Am J Psychiatry 2002;159:255-262.
    • (2002) Am J Psychiatry , vol.159 , pp. 255-262
    • Volavka, J.1    Czobor, P.2    Sheitman, B.3
  • 20
    • 0031748732 scopus 로고    scopus 로고
    • Olanzapine compared with chlorpromazine in treatment-resistant schizophrenia
    • CONLEY RR, TAMMINGA CA, BARTKO JJ et al. Olanzapine compared with chlorpromazine in treatment-resistant schizophrenia. Am J Psychiatry 1998;155:914-920.
    • (1998) Am J Psychiatry , vol.155 , pp. 914-920
    • Conley, R.R.1    Tamminga, C.A.2    Bartko, J.J.3
  • 21
    • 0032986659 scopus 로고    scopus 로고
    • Treatment-resistant schizophrenic patients respond to clozapine after olanzapine non-response
    • CONLEY RR, TAMMINGA CA, KELLY DL, RICHARDSON CM. Treatment-resistant schizophrenic patients respond to clozapine after olanzapine non-response. Biol Psychiatry 1999;46:7377.
    • (1999) Biol Psychiatry , vol.46 , pp. 7377
    • Conley, R.R.1    Tamminga, C.A.2    Kelly, D.L.3    Richardson, C.M.4
  • 22
    • 0041659128 scopus 로고    scopus 로고
    • Conventional antipsychotic drugs for treatment-resistant schizophrenia: A re-examination
    • MONCRIEFF J, CLOZAPINE V. conventional antipsychotic drugs for treatment-resistant schizophrenia: a re-examination. Br J Psychiatry 2003;183:161-166.
    • (2003) Br J Psychiatry , vol.183 , pp. 161-166
    • Moncrieff, J.1    Clozapine, V.2
  • 23
    • 0024989576 scopus 로고
    • Effects of six months of clozapine treatment on the quality of life of chronic schizophrenic patients
    • MELTZER HY, BURNETT S, BASTANI B, RAMIREZ L. Effects of six months of clozapine treatment on the quality of life of chronic schizophrenic patients. Hosp Comm Psychiatry 1990;41:892-897.
    • (1990) Hosp Comm Psychiatry , vol.41 , pp. 892-897
    • Meltzer, H.Y.1    Burnett, S.2    Bastani, B.3    Ramirez, L.4
  • 24
    • 1542641522 scopus 로고    scopus 로고
    • Olanzapine versus haloperidol in the treatment of schizophrenia and other psychotic disorders: Quality of life and clinical outcomes of a randomized clinical trial
    • REVICKI DA, GENDUSO LA, HAMILTON SH, GANOCZY D, BEASLEY CM Jr. Olanzapine versus haloperidol in the treatment of schizophrenia and other psychotic disorders: quality of life and clinical outcomes of a randomized clinical trial. Qual Life Res 1999;8:417-426.
    • (1999) Qual Life Res , vol.8 , pp. 417-426
    • Revicki, D.A.1    Genduso, L.A.2    Hamilton, S.H.3    Ganoczy, D.4    Beasley Jr., C.M.5
  • 25
    • 0031905314 scopus 로고    scopus 로고
    • Olanzapine versus placebo and haloperidol: Quality of life and efficacy results of the North American double blind trial
    • HAMILTON S, REVICKI D, GENDUSO L, BEASLE C. Olanzapine versus placebo and haloperidol: quality of life and efficacy results of the North American double blind trial. Neuropsychopharmacology 1998;18:41-49.
    • (1998) Neuropsychopharmacology , vol.18 , pp. 41-49
    • Hamilton, S.1    Revicki, D.2    Genduso, L.3    Beasle, C.4
  • 26
    • 0035972707 scopus 로고    scopus 로고
    • Improvement of schizophrenic patients' subjective well-being under atypical antipsychotic drugs
    • NABER D, MORITZ S, LAMBERT M et al. Improvement of schizophrenic patients' subjective well-being under atypical antipsychotic drugs. Schizophr Res 2001;50:79-88.
    • (2001) Schizophr Res , vol.50 , pp. 79-88
    • Naber, D.1    Moritz, S.2    Lambert, M.3
  • 27
    • 0035987323 scopus 로고    scopus 로고
    • Psychometric properties of the Subjective Well-Being under Neuroleptics scale and the Subjective Deficit Syndrome Scale
    • DE HAAN L, WEISFELT M, DINGEMANS PM, LINSZEN DH, WOUTERS L. Psychometric properties of the Subjective Well-Being Under Neuroleptics scale and the Subjective Deficit Syndrome Scale. Psychopharmacology (Berl) 2002;162:24-28.
    • (2002) Psychopharmacology (Berl) , vol.162 , pp. 24-28
    • De Haan, L.1    Weisfelt, M.2    Dingemans, P.M.3    Linszen, D.H.4    Wouters, L.5
  • 29
    • 0023606101 scopus 로고
    • The Positive and Negative Syndrome Scale (PANSS) for schizophrenia
    • KAY SR, FISZBEIN A, OPLER LA. The Positive and Negative Syndrome Scale (PANSS) for schizophrenia. Schizophrenia Bull 1987;13:261-276.
    • (1987) Schizophrenia Bull , vol.13 , pp. 261-276
    • Kay, S.R.1    Fiszbein, A.2    Opler, L.A.3
  • 30
    • 0001957397 scopus 로고
    • Psychometric testing of the "Münchner Lebensqualitäts Dimensionen Liste (MLDL)
    • Bullinger M, Ludwig M, Steinbüchel V, eds . Göttingen, Toronto, Zürich: Hogrefe Verlag für Psychologie
    • HEINISCH M, LUDWIG M, BULLINGER M. Psychometric testing of the "Münchner Lebensqualitäts Dimensionen Liste (MLDL). In: BULLINGER M, LUDWIG M, STEINBüCHEL V, eds. Lebensqualität bei kardiovaskulären Erkrankungen. Göttingen, Toronto, Zürich: Hogrefe Verlag für Psychologie, 1991.
    • (1991) Lebensqualität Bei Kardiovaskulären Erkrankungen
    • Heinisch, M.1    Ludwig, M.2    Bullinger, M.3
  • 31
  • 32
    • 0003412410 scopus 로고
    • Rockville, MD: National Institute of Mental Health, Dhew Publication No. (Adm)
    • GUY W. Assessment manual for psychopharmacology, revised. Rockville, MD: National Institute of Mental Health, Dhew Publication No. (Adm), 1976:76-338.
    • (1976) Assessment Manual for Psychopharmacology, Revised , pp. 76-338
    • Guy, W.1
  • 34
    • 0032529072 scopus 로고    scopus 로고
    • Therapeutic equivalence investigations: Statistical considerations
    • RÖHMEL J. Therapeutic equivalence investigations: statistical considerations. Stat Med 1998;17:1703-1714.
    • (1998) Stat Med , vol.17 , pp. 1703-1714
    • Röhmel, J.1
  • 35
    • 14344253616 scopus 로고    scopus 로고
    • Rapid improvement of subjective well-being after successful switch of psychotic outpatients to Olanzapine: Results from an open-label phase III study
    • in press
    • KLUGE M, KESSLER F, LANGER F et al. Rapid improvement of subjective well-being after successful switch of psychotic outpatients to Olanzapine: results from an open-label phase III study. Pharmacopsychiatry 2005 (in press).
    • (2005) Pharmacopsychiatry
    • Kluge, M.1    Kessler, F.2    Langer, F.3
  • 36
    • 14344256502 scopus 로고    scopus 로고
    • Association of clinical and non-clinical factors with subjective well-being: Data of the SOHO study
    • KAROW A, RITZHAUPT A, ROESCH F, NOVICK D, NABER D, DITTMANN RW. Association of clinical and non-clinical factors with subjective well-being: data of the SOHO study. Pharmacopsychiatry 2003;36:239.
    • (2003) Pharmacopsychiatry , vol.36 , pp. 239
    • Karow, A.1    Ritzhaupt, A.2    Roesch, F.3    Novick, D.4    Naber, D.5    Dittmann, R.W.6
  • 37
    • 0030756517 scopus 로고    scopus 로고
    • Comparison of clozapine and haloperidol in hospitalised patients with refractory schizophrenia
    • Department of Veterans Affairs Cooperative Study Group on Clozapine in Refractory Schizophrenia
    • ROSENHECK R, CRAMER J, XU W et al. Comparison of clozapine and haloperidol in hospitalised patients with refractory schizophrenia. Department of Veterans Affairs Cooperative Study Group on Clozapine in Refractory Schizophrenia. N Engl J Med 1997;337:809-815.
    • (1997) N Engl J Med , vol.337 , pp. 809-815
    • Rosenheck, R.1    Cramer, J.2    Xu, W.3
  • 38
    • 10744231049 scopus 로고    scopus 로고
    • Olanzapine versus clozapine in treatment-resistant or treatment-intolerant schizophrenia
    • BITTER I, DOSSENBACH MR, BROOK S et al. Olanzapine versus clozapine in treatment-resistant or treatment-intolerant schizophrenia. Progr Neuro-Psychopharmacol Biol Psychiatry 2004;28:173-180.
    • (2004) Progr Neuro-Psychopharmacol Biol Psychiatry , vol.28 , pp. 173-180
    • Bitter, I.1    Dossenbach, M.R.2    Brook, S.3
  • 39
    • 0028072032 scopus 로고
    • Clozapine dose in the United States and Europe: Implications for therapeutic and adverse effects
    • FLEISCHHACKER W, HUMMER M, KURZ M et al. Clozapine dose in the United States and Europe: implications for therapeutic and adverse effects. J Clin Psychiatry 1994;55(Suppl. 9):78-81.
    • (1994) J Clin Psychiatry , vol.55 , Issue.SUPPL. 9 , pp. 78-81
    • Fleischhacker, W.1    Hummer, M.2    Kurz, M.3
  • 40
    • 0024998253 scopus 로고
    • The European experience with the use of clozapine
    • NABER D, HIPPIUS H. The European experience with the use of clozapine. Hosp Com Psychiatry 1990;41:886-890.
    • (1990) Hosp Com Psychiatry , vol.41 , pp. 886-890
    • Naber, D.1    Hippius, H.2
  • 41
    • 0037227192 scopus 로고    scopus 로고
    • Clozapine treatment for suicidality in schizophrenia
    • MELTZER HY, ALPHS L, GREEN AI et al, for the InterSePT Study Group. Clozapine treatment for suicidality in schizophrenia. Arch Gen Psychiatry 2003;60:82-91.
    • (2003) Arch Gen Psychiatry , vol.60 , pp. 82-91
    • Meltzer, H.Y.1    Alphs, L.2    Green, A.I.3
  • 42
    • 0030097546 scopus 로고    scopus 로고
    • Dose related response to clozapine in a state psychiatric hospital population: A naturalistic study
    • GORDON BJ, MILKE DJ. Dose related response to clozapine in a state psychiatric hospital population: a naturalistic study. Psychiatr Q 1996;67:65-74.
    • (1996) Psychiatr Q , vol.67 , pp. 65-74
    • Gordon, B.J.1    Milke, D.J.2
  • 43
    • 0028810763 scopus 로고
    • A comparison of European and American dosing regimens of schizophrenic patients on clozapine: Efficacy and side effects
    • POLLACK S, LIEBERMAN JA, FLEISCHHACKER WW et al. A comparison of European and American dosing regimens of schizophrenic patients on clozapine: efficacy and side effects. Psychopharmacol Bull 1995;31:315-320.
    • (1995) Psychopharmacol Bull , vol.31 , pp. 315-320
    • Pollack, S.1    Lieberman, J.A.2    Fleischhacker, W.W.3
  • 44
    • 0032751075 scopus 로고    scopus 로고
    • Antipsychotic-induced weight gain: A comprehensive research synthesis
    • ALLISON DB, MENTORE JL, HEO M et al. Antipsychotic-induced weight gain: a comprehensive research synthesis. Am J Psychiatry 1999;156:1686-1696.
    • (1999) Am J Psychiatry , vol.156 , pp. 1686-1696
    • Allison, D.B.1    Mentore, J.L.2    Heo, M.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.